magyarcég
Egészségügy
  • Egészségügy

Johnson & Johnson Innovative Medicine

Pharmaceutical company developing and providing innovative medicines.

  • RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib)
  • IMAAVY™ (nipocalimab-aahu)
  • TREMFYA® (guselkumab)

Bemutatkozás

Johnson & Johnson Innovative Medicine focuses on the development and provision of groundbreaking medicines globally. The company conducts rigorous scientific research to create transformational medical innovations. Its primary therapeutic areas of focus include oncology, immunology, neuroscience, and cardiopulmonary conditions. The company offers specific products such as RYBREVANT® plus LAZCLUZE™, IMAAVY™, and TREMFYA®.

Szolgáltatások, tevékenységek

  • RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib)
  • IMAAVY™ (nipocalimab-aahu)
  • TREMFYA® (guselkumab)